Concepedia

Publication | Open Access

Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis

DOIFull Paper Access

45

Citations

32

References

2011

Year

Suzanne Arends, E. van der Veer, Henk Groen, PIETERNELLA M. HOUTMAN, Tim Jansen, M. K. Leijsma, Johan Bijzet, Pieter C. Limburg, Cees G. M. Kallenberg, Anneke Spoorenberg,
The Journal of Rheumatology

Abstract

Although significant changes in serum MMP-3 levels were found after etanercept treatment, data analysis indicates that serum MMP-3 levels are not very useful for monitoring and predicting response to etanercept treatment in patients with AS in daily clinical practice.

References

YearCitations

Page 1